SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-19-000364
Filing Date
2019-02-13
Accepted
2019-02-13 09:25:54
Documents
2
Period of Report
2019-02-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cannabics_8k.htm 8-K 19254
2 JOINT VENTURE AGREEMENT cannabics_8k-ex1001.htm EX-10.1 72196
  Complete submission text file 0001683168-19-000364.txt   92850
Mailing Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 877-424-2429
Cannabics Pharmaceuticals Inc. (Filer) CIK: 0001343009 (see all company filings)

IRS No.: 203373669 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 000-52403 | Film No.: 19593551
SIC: 2834 Pharmaceutical Preparations